Thomas Dale Penning

This inventor holds 93 USPTO granted patents and 24 published patent applications, plus 10 CIPO patents and 20 EPO patents, primarily in Kinase Inhibitors (CPC class C07D-). Top assignees: G.d. Searle & Company, Abbvie Inc., Abbott Laboratories Corporation. Active years: 1990-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Dale Penning. Retrieved from https://idiyas.com/inventor/thomas-dale-penning

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 93 (Patent Applications = 24)

% Patents Active = 84.9

CIPO Patents = 10 (Patent Applications = 30)

EPO Patents = 20 (Patent Applications = 30)

Average Co-Inventor Count = 6.0

ph-index = 15

Forward Citations = 959(Granted Patents)

Forward Citations (Not Self Cited) = 923(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Des Plaines, IL (US) (1990 - 1999)
Emhurst, IL (US) (1999 - 2001)
Elmhurst, IL (US) (1991 - 2020)

Company Filing History:

38 out of 1,323

G.d. Searle & Company

Abbott Laboratories Corporation

patents

4. 13 out of 220

Pharmacia Corporation

patents

5. 3 out of 834,570

Other

patents

Years Active: 1990-2020

Loading Chart...

Areas of Expertise:

CDK9 Kinase Inhibitors

PARP Inhibitors

Macrocyclic Inhibitors

Bicyclic Inhibitors

Thieno[3,2-d]pyrimidine

Pyridopyrimidinone

Pyrrolopyridine

Indazoles

Poly(ADP-Ribose) Polymerase

Pyrrolopyrazinone

Tricyclic Inhibitors

Picolinamide

93 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10676485 - Macrocyclic MCL-1 inhibitors and methods of use (2020-06-09),

2. 9796708 - Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors (2017-10-24),

3. 9718821 - Pyridopyrimidinone inhibitors of kinases (2017-08-01),

4. 9650358 - Pyridine CDK9 kinase inhibitors (2017-05-16),

5. 9346813 - Substituted pyrrolo[2,3-d]pyrimindines as CDK9 kinase inhibitors (2016-05-24),

6. 9328112 - Tetracyclic CDK9 kinase inhibitors (2016-05-03),

7. 9283222 - Inhibitors of poly(ADP-ribose)polymerase (2016-03-15),

8. 9212192 - Bicyclic carboxamide inhibitors of kinases (2015-12-15),

9. 9181246 - Pyrrolopyridine inhibitors of kinases (2015-11-10),

10. 9181239 - Pyridopyrimidinone inhibitors of kinases (2015-11-10),

11. 9163007 - 5-substituted indazoles as kinase inhibitors (2015-10-20),

12. 9073922 - Pyrrolo[2,3-B]pyridine CDK9 kinase inhibitors (2015-07-07),

13. 9051327 - Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases (2015-06-09),

14. 8969375 - CDK9 kinase inhibitors (2015-03-03),

15. 8859546 - Picolinamide inhibitors of kinases (2014-10-14),

Title: The Legacy of Innovation: Thomas Dale Penning

Introduction:

Thomas Dale Penning, a visionary inventor hailing from Elmhurst, IL (US), has left an indelible mark on the world of technology through his passion for innovation and relentless pursuit of excellence. With an impressive portfolio of 93 patents to his name, Penning continues to inspire the next generation of inventors.

Latest Patents:

Among his latest patents are groundbreaking inventions such as the Macrocyclic MCL-1 inhibitors and methods of use. These compounds, along with the Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors, showcase Penning's commitment to developing cutting-edge solutions for the treatment of diseases, including cancer.

Career Highlights:

Throughout his career, Penning has made significant contributions to renowned companies such as G.D. Searle & Company and AbbVie Inc. His innovative spirit and dedication to pushing the boundaries of technology have been instrumental in shaping the industry.

Collaborations:

Penning has collaborated with esteemed professionals in the field, including coworkers like Julie M. Miyashiro and James W. Malecha. Together, they have worked tirelessly to bring his groundbreaking inventions to life and advance the frontiers of science.

Conclusion:

In conclusion, Thomas Dale Penning's legacy as an inventor is characterized by his unwavering commitment to innovation and his transformative impact on the world of technology. His pioneering work serves as a beacon of inspiration for inventors and innovators everywhere, leaving a lasting imprint on the landscape of patents and inventions.

Profile summary based on public USPTO records.